{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:10:32Z","timestamp":1783955432533,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Disability and Ageing","doi-asserted-by":"publisher","award":["APP1201062"],"award-info":[{"award-number":["APP1201062"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03851-x","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:35:10Z","timestamp":1779197710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma proteome in LGI-1 autoimmune encephalitis"],"prefix":"10.1186","volume":"23","author":[{"given":"Robb","family":"Wesselingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Seery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Giesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Rushen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirasol","family":"Forcadela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendyl","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kalincik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Macdonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Malpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Australian Autoimmune Encephalitis Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"3851_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776\u201385.","journal-title":"Lancet Neurol"},{"key":"3851_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577598","volume":"357","author":"L Zuliani","year":"2021","unstructured":"Zuliani L, Marangoni S, De Gaspari P, Rosellini I, Nosadini M, Fleming JM, et al. Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics. J Neuroimmunol. 2021;357:577598.","journal-title":"J Neuroimmunol"},{"key":"3851_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87:1449\u201356.","journal-title":"Neurology"},{"key":"3851_CR4","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","volume":"33","author":"T Ohkawa","year":"2013","unstructured":"Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci. 2013;33:18161\u201374.","journal-title":"J Neurosci"},{"key":"3851_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1314-2","volume":"15","author":"Y Jang","year":"2018","unstructured":"Jang Y, Lee ST, Bae JY, Kim TJ, Jun JS, Moon J, et al. LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis. J Neuroinflammation. 2018;15:279.","journal-title":"J Neuroinflammation"},{"key":"3851_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200412","volume":"12","author":"N Seery","year":"2025","unstructured":"Seery N, Wesselingh R, Beech P, McLaughlin LM, Rushen T, Halliday AJ, et al. Acute and long-term immune-treatment strategies in anti-LGI1 antibody-mediated encephalitis: A multicenter cohort study. Neurol Neuroimmunol Neuroinflamm. 2025;12:e200412.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3851_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/jamaneurol.2021.0477","volume":"78","author":"SNM Binks","year":"2021","unstructured":"Binks SNM, Veldsman M, Easton A, Leite MI, Okai D, Husain M, et al. Residual fatigue and cognitive deficits in patients after Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis. JAMA Neurol. 2021;78:617\u20139.","journal-title":"JAMA Neurol"},{"key":"3851_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/acn3.52006","volume":"11","author":"SNM Binks","year":"2024","unstructured":"Binks SNM, Veldsman M, Handel AE, Jacob S, Maddison P, Coebergh J, et al. Fatigue predicts quality of life after Leucine-rich Glioma-inactivated 1-antibody encephalitis. Ann Clin Transl Neurol. 2024;11:1053\u20138.","journal-title":"Ann Clin Transl Neurol"},{"key":"3851_CR9","doi-asserted-by":"publisher","unstructured":"Lehmann-HornK, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, et al: Intrathecal B-cell activation in LGI1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm 2020;7:2:e669. https:\/\/doi.org\/10.1212\/NXI.0000000000000669.","DOI":"10.1212\/NXI.0000000000000669"},{"key":"3851_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311049121","volume":"121","author":"J Theorell","year":"2024","unstructured":"Theorell J, Harrison R, Williams R, Raybould MIJ, Zhao M, Fox H, et al. Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis. Proc Natl Acad Sci U S A. 2024;121:e2311049121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3851_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s10072-022-06526-6","volume":"44","author":"S Qiao","year":"2023","unstructured":"Qiao S, Zhang SC, Li HY, Wang ZH, Jin Y, Wang AH, et al. Cytokines\/chemokines and immune checkpoint molecules in anti-Leucine-rich Glioma-inactivated 1 encephalitis. Neurol Sci. 2023;44:1017\u201329.","journal-title":"Neurol Sci"},{"key":"3851_CR12","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/acn3.70158","volume":"12","author":"A Aboseif","year":"2025","unstructured":"Aboseif A, Mangioris G, Yang B, Pazdernik VK, Britton JW, Dubey D, et al. Cytokine, chemokine, and Neurofilament Light Chain signatures in LGI1 autoimmune encephalitis. Ann Clin Transl Neurol. 2025;12:2258\u201370.","journal-title":"Ann Clin Transl Neurol"},{"key":"3851_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200492","volume":"12","author":"G Munoz-Sanchez","year":"2025","unstructured":"Munoz-Sanchez G, Guasp M, Munoz-Lopetegi A, Luchoro JF, Martinez-Hernandez E, Naranjo L, et al. Cytokine and chemokine profiles in Anti-LGI1 encephalitis: Markers of severity and outcome. Neurol Neuroimmunol Neuroinflamm. 2025;12:e200492.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3851_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102985","volume":"135","author":"S Rauber","year":"2023","unstructured":"Rauber S, Schroeter CB, Strippel C, Nelke C, Ruland T, Dik A, et al. Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis. J Autoimmun. 2023;135:102985.","journal-title":"J Autoimmun"},{"key":"3851_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103000","volume":"135","author":"R Wesselingh","year":"2023","unstructured":"Wesselingh R, Griffith S, Broadley J, Tarlinton D, Buzzard K, Seneviratne U, et al. Peripheral monocytes and soluble biomarkers in autoimmune encephalitis. J Autoimmun. 2023;135:103000.","journal-title":"J Autoimmun"},{"key":"3851_CR16","unstructured":"Voo V, Butzkueven H, O'Brien T, Monif M: A Simple and Efficient Monocyte Isolation Protocol from Human Peripheral Blood. Journal of Clinical & Experimental Neuroimmunology. 2019;4:1."},{"key":"3851_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2025.106206","volume":"132","author":"R Wesselingh","year":"2025","unstructured":"Wesselingh R, Griffith S, Ko K, Seery N, Kazzi C, O\u2019Brien WT, et al. Biomarkers of neuroaxonal and astrocytic pathology in autoimmune encephalitis. Brain Behav Immun. 2025;132:106206.","journal-title":"Brain Behav Immun"},{"key":"3851_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3851_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1437913","volume":"15","author":"ST Lee","year":"2024","unstructured":"Lee ST, Abboud H, Irani SR, Nakajima H, Piquet AL, Pittock SJ, et al. Innovation and optimization in autoimmune encephalitis trials: The design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO). Front Neurol. 2024;15:1437913.","journal-title":"Front Neurol"},{"key":"3851_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1128\/cdli.3.2.175-183.1996","volume":"3","author":"S Stove","year":"1996","unstructured":"Stove S, Welte T, Wagner TO, Kola A, Klos A, Bautsch W, et al. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol. 1996;3:175\u201383.","journal-title":"Clin Diagn Lab Immunol"},{"key":"3851_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMoa1900866","volume":"381","author":"SJ Pittock","year":"2019","unstructured":"Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, et al. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2019;381:614\u201325.","journal-title":"N Engl J Med"},{"key":"3851_CR22","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100066","volume":"1","author":"T Vu","year":"2022","unstructured":"Vu T, Meisel A, Mantegazza R, Annane D, Katsuno M, Aguzzi R, et al. Terminal complement inhibitor Ravulizumab in generalized Myasthenia Gravis. NEJM Evid. 2022;1:EVIDoa2100066.","journal-title":"NEJM Evid"},{"key":"3851_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/acn3.561","volume":"5","author":"A Gadoth","year":"2018","unstructured":"Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, et al. Elevated LGI1-IgG CSF index predicts worse neurological outcome. Ann Clin Transl Neurol. 2018;5:646\u201350.","journal-title":"Ann Clin Transl Neurol"},{"key":"3851_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.173.4.1025","volume":"173","author":"MH Tao","year":"1991","unstructured":"Tao MH, Canfield SM, Morrison SL. The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. J Exp Med. 1991;173:1025\u20138.","journal-title":"J Exp Med"},{"key":"3851_CR25","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1007\/s00415-024-12594-9","volume":"271","author":"CG Bien","year":"2024","unstructured":"Bien CG, Rada A, Mertens M, Bien CI, Bauer J, Hagemann A, et al. LGI1 encephalitis: potentially complement-activating anti-LGI1-IgG subclasses 1\/2\/3 are associated with the development of hippocampal sclerosis. J Neurol. 2024;271:6325\u201335.","journal-title":"J Neurol"},{"key":"3851_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00109-015-1297-8","volume":"93","author":"Z Yang","year":"2015","unstructured":"Yang Z, Goronzy JJ, Weyand CM. Autophagy in autoimmune disease. J Mol Med (Berl). 2015;93:707\u201317.","journal-title":"J Mol Med (Berl)"},{"key":"3851_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/imr.12613","volume":"281","author":"M Takahama","year":"2018","unstructured":"Takahama M, Akira S, Saitoh T. Autophagy limits activation of the inflammasomes. Immunol Rev. 2018;281:62\u201373.","journal-title":"Immunol Rev"},{"key":"3851_CR28","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.4049\/jimmunol.0801320","volume":"182","author":"NJ Rogers","year":"2009","unstructured":"Rogers NJ, Lees MJ, Gabriel L, Maniati E, Rose SJ, Potter PK, et al. A defect in Marco expression contributes to Systemic Lupus Erythematosus development via failure to clear apoptotic cells. J Immunol. 2009;182:1982\u201390.","journal-title":"J Immunol"},{"key":"3851_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ng2032","volume":"39","author":"JD Rioux","year":"2007","unstructured":"Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596\u2013604.","journal-title":"Nat Genet"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03851-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:02:40Z","timestamp":1783954960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03851-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3851"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03851-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Human Research Ethics Committee at Alfred Health (HREC\/17\/Alfred\/168) approved the study, with institutional review board (IRB) approval from all participating sites. All research was performed in accordance with relevant guidelines\/regulations and in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}